Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 67,482 | 53,883 | 0 | 0 | 0 |
| Cost of Goods | 57 | N/A | N/A | N/A | N/A |
| Gross Profit | 67,425 | 53,883 | N/A | N/A | N/A |
| Operating Expenses | 371,113 | 247,078 | 165,804 | 139,865 | 131,258 |
| Operating Income | -303,631 | -193,195 | -165,804 | -139,865 | -131,258 |
| Interest Expense | 1,512 | 1,619 | 1,549 | 229 | 414 |
| Other Income | 26,774 | 22,849 | 14,722 | 4,254 | 1,206 |
| Pre-tax Income | -278,369 | -171,965 | -152,631 | -135,840 | -130,466 |
| Income Tax | 297 | 2,018 | N/A | N/A | N/A |
| Net Income Continuous | -278,666 | -173,983 | -152,631 | -135,840 | -130,466 |
| Net Income | $-278,666 | $-173,983 | $-152,631 | $-135,840 | $-130,466 |
| EPS Basic Total Ops | -3.18 | -2.02 | -2.08 | -2.03 | -1.97 |
| EPS Basic Continuous Ops | -3.18 | -2.02 | -2.08 | -2.03 | -1.97 |
| EPS Diluted Total Ops | -3.18 | -2.02 | -2.08 | -2.03 | -1.97 |
| EPS Diluted Continuous Ops | -3.18 | -2.02 | -2.08 | -2.03 | -1.97 |
| EPS Diluted Before Non-Recurring Items | -3.18 | -2.02 | -2.08 | -2.03 | -1.97 |
| EBITDA(a) | $-311,087 | $-205,488 | $-174,375 | $-137,496 | $-126,309 |